Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02906644 · ClinicalTrials.gov registry record · Phase 2
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 97
- Enrollment target
NCT02906644 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 97 participants.
The verdict
NCT02906644, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 97 participants
- Enrollment target
Study Summary
This study plans to compare the efficacy of the nicotine patch / lorcaserin combination treatment vs. the nicotine patch alone in terms of leading to a reduction in smoking behavior and withdrawal symptoms.
Interventions
- DRUG nicotine patch
- DRUG lorcaserin
- DRUG placebo lorcaserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2016-11-08 |
| Est. Completion | 2018-10-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02906644
The ClinicalTrials.gov registry entry for NCT02906644 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which nicotine patch is the first listed.
NCT02906644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02906644 about?
NCT02906644 is a clinical study titled "Combination Nicotine Patch / Lorcaserin for Smoking Cessation". This study plans to compare the efficacy of the nicotine patch / lorcaserin combination treatment vs. the nicotine patch alone in terms of leading to a reduction in smoking behavior and withdrawal symptoms.
What is the current status of trial NCT02906644?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2016-11-08. Estimated completion is 2018-10-18.
What interventions are being tested in trial NCT02906644?
The interventions under investigation include: nicotine patch (DRUG), lorcaserin (DRUG), placebo lorcaserin (DRUG).
Who is sponsoring clinical trial NCT02906644?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.